1453113-39-7

Basic information

• Product Name: N-cyclohexyl N-methyl-2E,6E,10E-geranylgeranyl amine
• Synonyms: N-cyclohexyl N-methyl-2E,6E,10E-geranylgeranyl amine
• CAS NO: 1453113-39-7
• Molecular Weight: 385.677
• Mol File: 1453113-39-7.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: N-cyclohexyl N-methyl-2E,6E,10E-geranylgeranyl amine(CAS DataBase Reference)
• NIST Chemistry Reference: N-cyclohexyl N-methyl-2E,6E,10E-geranylgeranyl amine(1453113-39-7)
• EPA Substance Registry System: N-cyclohexyl N-methyl-2E,6E,10E-geranylgeranyl amine(1453113-39-7)

Safety Data

• Hazardous Substances Data: 1453113-39-7(Hazardous Substances Data)

Upstream product

• 51921-98-3 (4E,8E)-ethyl 2-acetyl-5,9,13-trimethyltetradeca-4,8,12-trienoate 
• 24163-93-7 farnesyl bromide 
• 106-28-5 Farnesol 
• 100-60-7 N-methylcyclohexylamine 
• 24034-73-9 Geranylgeraniol 
• 24035-35-6 (2E,6E,10E)-3,7,11,15-tetramethyl-hexadeca-2,6,10,14-tetraenoic acid ethyl ester 
• 1117-52-8 6,10,14-trimethyl-5,9,13-pentadecatriene-2-on 

Relevant articles and documents

GGA AND GGA DERIVATIVES COMPOSITIONS THEREOF AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES INCLUDING PARALYSIS INCLUDING THEM

This invention relates to geranylgeranyl acetone (GGA) derivatives and the use of GGA, its isomers, and GGA derivatives in methods for inhibiting neural death, increasing neural activity, increasing axon growth and cell viability, and increasing the survival rate of subjects administered the GGA or GGA derivatives.